Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianping Weng

Showing results (71-80 of 295) with videos related to

Pageof 30
Sort By:
Frontiers in Immunology|June 24, 2021
Metformin, Macrophage Dysfunction and AtherosclerosisXiaojun Feng, Wenxu Chen, Xiayun Ni, et al.
Frontiers in Psychology|April 6, 2023
COVID-19 symptoms and compliance: The mediating role of fundamental social motivesRuoting Liu, Xueying Zheng, Ziyu Wang, et al.
Endocrinology|March 27, 2010
Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammationFen Xu, Zhanguo Gao, Jin Zhang, et al.
Signal Transduction and Targeted Therapy|May 27, 2023
Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapiesXiumei Wu, Mengyun Xu, Mengya Geng, et al.
Diabetes Care|October 27, 2004
Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell functionYanbing Li, Wen Xu, Zhihong Liao, et al.
Acta Diabetologica|August 8, 2015
Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetesRenyuan Li, Wen Xu, Sihui Luo, et al.
Journal of Diabetes|December 7, 2018
Effect of baseline body mass index on glycemic control and weight change with exenatide monotherapy in Chinese drug-naïve type 2 diabetic patientsHongrong Deng, Shuo Lin, Xubin Yang, et al.
The Journal of Nutrition|September 5, 2015
Short-Term Curcumin Gavage Sensitizes Insulin Signaling in Dexamethasone-Treated C57BL/6 MiceLili Tian, Kejing Zeng, Weijuan Shao, et al.
BMJ (Clinical Research Ed.)|January 5, 2018
Incidence of type 1 diabetes in China, 2010-13: population based studyJianping Weng, Zhiguang Zhou, Lixin Guo, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trialMichael Roden, Jianping Weng, Jens Eilbracht, et al.
Pageof 30

Showing results (71-80 of 295) with videos related to

Sort By:
Pageof 30
Frontiers in Immunology|June 24, 2021
Metformin, Macrophage Dysfunction and AtherosclerosisXiaojun Feng, Wenxu Chen, Xiayun Ni, et al.
Frontiers in Psychology|April 6, 2023
COVID-19 symptoms and compliance: The mediating role of fundamental social motivesRuoting Liu, Xueying Zheng, Ziyu Wang, et al.
Endocrinology|March 27, 2010
Lack of SIRT1 (Mammalian Sirtuin 1) activity leads to liver steatosis in the SIRT1+/- mice: a role of lipid mobilization and inflammationFen Xu, Zhanguo Gao, Jin Zhang, et al.
Signal Transduction and Targeted Therapy|May 27, 2023
Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapiesXiumei Wu, Mengyun Xu, Mengya Geng, et al.
Diabetes Care|October 27, 2004
Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell functionYanbing Li, Wen Xu, Zhihong Liao, et al.
Acta Diabetologica|August 8, 2015
Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetesRenyuan Li, Wen Xu, Sihui Luo, et al.
Journal of Diabetes|December 7, 2018
Effect of baseline body mass index on glycemic control and weight change with exenatide monotherapy in Chinese drug-naïve type 2 diabetic patientsHongrong Deng, Shuo Lin, Xubin Yang, et al.
The Journal of Nutrition|September 5, 2015
Short-Term Curcumin Gavage Sensitizes Insulin Signaling in Dexamethasone-Treated C57BL/6 MiceLili Tian, Kejing Zeng, Weijuan Shao, et al.
BMJ (Clinical Research Ed.)|January 5, 2018
Incidence of type 1 diabetes in China, 2010-13: population based studyJianping Weng, Zhiguang Zhou, Lixin Guo, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trialMichael Roden, Jianping Weng, Jens Eilbracht, et al.
Pageof 30